RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ExcellentI will say it again. I don't like the deal, I was not expecting it two days after the news, so I understand the frustrations. That being said, I don't think management and board are fools. Also, if you are in this stock for the long run, believing in the two clinical programs, dilution should not disturb you that much because there will be a good way to counter that at some point if they end up with positive results in one trial or both. If there is real clinical success, the SP will rise too much at some point, like when it went to 14$ after approval of Trogarzo. A way to compensate for the dilution will be to sell when the market will be irrationally positive. If both trial are failures, then dilution will not mean much. So if you believed in the two clinical programs, it means that if you are right, there will be an exit point that will compensate for the dilution, and remember that selling at a high point does not prevent you to buy it back later.